Cancer levels by country
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Global Cancer Levels by Country
Global Cancer Incidence and Mortality Rates
Cancer remains a significant global health challenge, with varying incidence and mortality rates across different countries. In 2020, there were an estimated 19.3 million new cancer cases and nearly 10 million cancer deaths worldwide. The most commonly diagnosed cancers globally were female breast cancer, lung cancer, and colorectal cancer, while lung cancer remained the leading cause of cancer death .
Regional Variations in Cancer Incidence
High-Income Countries
High-income countries (HICs) generally report higher cancer incidence rates compared to low- and middle-income countries (LMICs). This is attributed to better cancer detection and reporting systems, as well as lifestyle factors such as diet and smoking. For instance, the USA, Canada, Australia, and several European countries have some of the highest 5-year survival rates for various cancers, including breast, prostate, and colorectal cancers . In Europe, the most common cancers are breast, colorectal, lung, and prostate cancers, which together account for half of the overall cancer burden .
Low- and Middle-Income Countries
In contrast, LMICs face a growing cancer burden, with increasing incidence rates for cancers such as stomach, liver, esophageal, and cervical cancers. These countries often have higher mortality rates due to limited access to early detection and treatment facilities . For example, cervical cancer remains a leading cause of cancer death among women in many LMICs, particularly in Sub-Saharan Africa and Southern Asia.
Cancer Survival Rates
Survival rates for cancer vary significantly by region and type of cancer. For instance, 5-year survival rates for breast cancer are as high as 90.2% in the USA and 89.5% in Australia, but as low as 66.1% in India. Similarly, survival rates for gastrointestinal cancers are highest in Southeast Asia, with South Korea and Japan leading in stomach and esophageal cancer survival rates, respectively.
Trends and Future Projections
The global cancer burden is expected to rise significantly, with projections indicating 28.4 million new cases by 2040, a 47% increase from 2020. This rise will be more pronounced in transitioning countries due to demographic changes and increasing risk factors associated with globalization and economic growth. Efforts to build sustainable cancer prevention and care infrastructure in these countries are critical for global cancer control.
Conclusion
Cancer incidence and mortality rates exhibit significant regional variations, influenced by factors such as economic development, healthcare infrastructure, and lifestyle. High-income countries generally report higher incidence but better survival rates, while low- and middle-income countries face increasing cancer burdens with higher mortality rates. Addressing these disparities through improved cancer detection, prevention, and treatment strategies is essential for reducing the global cancer burden.
Sources and full results
Most relevant research papers on this topic